非アルコール性脂肪肝炎 治験結果
-
A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Sym
-
Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrho
-
Iron Reduction for the Treatment of Diabetes and Nonalcoholic Fatty Liver Disease
-
Effect of Obesity on Proton Pump Inhibitors
-
Alternate Dosing Study of MK-6024 in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (MAS
-
Phase 2a Study of HPG1860 in Subjects With NASH
-
Vitamin E Dosing Study
-
Study of Oral Idebenone to Treat Non-Alcoholic Steatohepatitis
-
A Study of LY3885125 in Participants With Dyslipidemia or Non-Alcoholic Fatty Liver Disease (NAFLD)
-
A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR)
-
A Phase 2 Study of Elobixibat in Adults With NAFLD or NASH
-
Pediatric Liver Fat Quantification (LFQ) Phase 2 Pilot Study
-
Ultrasound-Based Liver Fat Quantification (LFQ) Pilot Study
-
Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoh
-
The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease
疾患別の治験
肺がん非小細胞肺がん乳がん大腸がん胃がん肝がん膵臓がん前立腺がん卵巣がんメラノーマ白血病リンパ腫多発性骨髄腫膠芽腫2型糖尿病肥満症高血圧心不全心房細動脳卒中慢性腎臓病非アルコール性脂肪肝炎アルツハイマー病パーキンソン病多発性硬化症うつ病てんかんALS（筋萎縮性側索硬化症）関節リウマチ乾癬アトピー性皮膚炎クローン病潰瘍性大腸炎全身性エリテマトーデス喘息COPD（慢性閉塞性肺疾患）